Visible Light Study
Status: | Recruiting |
---|---|
Conditions: | Skin Cancer, Skin and Soft Tissue Infections |
Therapuetic Areas: | Dermatology / Plastic Surgery, Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/31/2019 |
Start Date: | September 2015 |
End Date: | April 2019 |
Contact: | Elise Kelman |
Email: | elise.kelman@nyumc.org |
Phone: | 212.263.9073 |
Determination of the Minimal Dose of Visible Light Required to Achieve Immediate Pigment Darkening, Persistent Pigment Darkening, and Delayed Tanning for Fitzpatrick Skin Types IV-VI Utilizing Two Visible Light Sources.
The purpose of this study is to learn more about the potential effects of visible light on
the skin. More specifically, this study will examine whether an incandescent lamp (light
bulb) or LED light bulb can cause skin to become darker. Investigators will determine the
minimum threshold dose required to achieve immediate pigmentation darkening (IPD), persistent
pigmentation darkening (PPD), and delayed tanning (DT) for Fitzpatrick skin types IV - VI
utilizing two visible light sources.
the skin. More specifically, this study will examine whether an incandescent lamp (light
bulb) or LED light bulb can cause skin to become darker. Investigators will determine the
minimum threshold dose required to achieve immediate pigmentation darkening (IPD), persistent
pigmentation darkening (PPD), and delayed tanning (DT) for Fitzpatrick skin types IV - VI
utilizing two visible light sources.
Inclusion Criteria:
- Be a healthy volunteer with Fitzpatrick skin types I-VI;
- Agree to abide by the Investigator's guidelines regarding photosensitizing drugs and
photoprotection;
- Be able to understand the requirements of the study, the risks involved, and be able
to sign the informed consent form;
- Agree to follow and undergo all study-related procedures.
Exclusion Criteria:
- Women who are lactating, pregnant, or planning to become pregnant;
- Patients with a recent history of vitiligo, melasma, and other disorders of
pigmentation with the exception of post-inflammatory hyperpigmentation;
- Patients with a known history of photosensitivity disorders;
- Photosensitizing medications may be continued throughout of the study at the
discretion of the investigator ;
- Patients with a known history of melanoma or non-melanoma skin cancers;
- Concomitant use of tanning beds;
- Sun exposure of the irradiated or control areas;
- Patients with serious systemic disease.
- Patients with a known history of hypersensitivity to adhesives including adhesive
tape.
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Nicholas Soter, MD
Phone: 212-263-9073
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials